Charles River Laboratories CRL · NYSE
$300.27 -1.95% (-$5.97)
Summary
35 / 100 · Bulios Score
What speaks for it
- It beat profit estimates 8 times in the last 8 quarters.
What to watch
- The company made a loss over the last 12 months.
- Repaying its net debt would take 12.9 years of operating profit.
- The share price is above the Bulios Fair Price.
- Revenue grew by only 0.3% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 6.5% a year over 5 years. Over the last 3 years it grew by 0.3% a year. For the next fiscal year analysts expect revenue to fall by 0.3%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $238.5M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 8.2 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 27
- Hold 10
- Sell 0
Today's price within the analysts' price targets
The average target of $305.5 is 1.7% above today's price. 73% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Discovery and Safety Assessment 60%
- Research Models and Services 21%
- Manufacturing Support 19%
By region
- UNITED STATES 54%
- Europe 28%
- CANADA 13%
- Asia Pacific 5.2%
Discovery and Safety Assessment brings in 60% of revenue. Research Models and Services grew fastest, by 5.2% a year.
Segments in detail